We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
MKS Inc
MKSI
$18.1B
| $19.2M | 0.05% |
177,909
-467
| -0.3% | -$42.7K |
|
402
TD Synnex
SNX
$20.9B
| $19.2M | 0.05% |
204,519
+198,769
| +3,457% | +$18.2M |
|
403
AGCO
AGCO
$8.48B
| $19.2M | 0.05% |
145,941
+2,951
| +2% | +$366K |
|
404
Pentair
PNR
$8.97B
| $19.2M | 0.05% |
296,844
-4,565
| -2% | -$263K |
|
|
SQSP
405
DELISTED
Squarespace, Inc.
SQSP
| $19.1M | 0.05% |
605,092
+547,344
| +948% | +$16.5M |
|
406
Tesla
TSLA
$1.42T
| $19.1M | 0.05% |
72,832
+4,844
| +7% | +$969K |
|
407
Elevance Health
ELV
$90.8B
| $19M | 0.05% |
42,861
+14,195
| +50% | +$6.55M |
|
408
General Motors
GM
$76.5B
| $19M | 0.05% |
493,797
+53,647
| +12% | +$1.86M |
|
409
Varonis Systems
VRNS
$5.45B
| $19M | 0.05% |
712,026
+353,931
| +99% | +$8.84M |
|
|
CFB
410
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $18.9M | 0.05% |
1,890,334
-7
| -0% | -$72 |
|
411
CAVA Group
CAVA
$6.41B
| $18.8M | 0.05% |
+460,000
| New | +$18.9M |
|
412
MetLife
MET
$61.7B
| $18.7M | 0.05% |
331,298
+12,000
| +4% | +$666K |
|
|
RDFN
413
DELISTED
Redfin
RDFN
| $18.3M | 0.05% |
1,474,614
-37,944
| -3% | -$370K |
|
414
eBay
EBAY
$48.5B
| $18.1M | 0.04% |
404,892
+3,428
| +0.9% | +$152K |
|
415
Skyworks Solutions
SWKS
$11.9B
| $17.9M | 0.04% |
161,510
-20,073
| -11% | -$2.12M |
|
416
Boeing
BA
$166B
| $17.9M | 0.04% |
84,642
+72,625
| +604% | +$15.1M |
|
417
Federated Hermes Short Duration High Yield ETF
FHYS
$54.8M
| $17.7M | 0.04% |
794,000
-50,000
| -6% | -$1.12M |
|
418
TE Connectivity
TEL
$58.9B
| $17.5M | 0.04% |
125,157
-42,309
| -25% | -$5.35M |
|
419
Nutanix
NTNX
$18.3B
| $17.4M | 0.04% |
621,866
-8,995
| -1% | -$239K |
|
420
Bio-Rad Laboratories Class A
BIO
$9.87B
| $17.4M | 0.04% |
45,857
-2,343
| -5% | -$953K |
|
|
DAY
421
DELISTED
Dayforce
DAY
| $17.4M | 0.04% |
259,561
-15,305
| -6% | -$985K |
|
422
Advance Auto Parts
AAP
$2.7B
| $17.3M | 0.04% |
245,781
+243,754
| +12,025% | +$25.1M |
|
423
Biogen
BIIB
$32.1B
| $17.1M | 0.04% |
60,140
-2,731
| -4% | -$813K |
|
424
Intel
INTC
$514B
| $17.1M | 0.04% |
512,239
+185,744
| +57% | +$5.83M |
|
425
DXC Technology
DXC
$1.94B
| $16.9M | 0.04% |
633,034
+6,925
| +1% | +$172K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.